Ir para o conteúdo principal

USANA Health Sciences (NYSE: USNA) — Perfil da empresa, notícias e dados financeiros

Logo de USANA Health Sciences
USNA USANA Health Sciences
USANA Health Sciences primary media
Perfil da empresa

USANA Health Sciences

USANA Health Sciences (NYSE:USNA) engages primarily in the development, manufacture, and sale of nutritional supplements, healthy foods, and personal care products. Focused on promoting healthy living, their extensive range of products is formulated to support the body's nutritional needs, fostering a global community keen on maintaining wellness and health. USANA's projects span across research and innovation to create scientifically-based products, emphasizing quality and efficacy. The company's objective is to empower individuals to achieve their health goals through superior products, promoting an ethos of wellbeing and preventive care. With operations spreading globally, USANA ensures its offerings meet the rigorous standards set by health authorities around the world, demonstrating a commitment to improving life quality for its customers.

Resumo

Public USParticipação acionária
1992Ano de fundação
1800Funcionários
Salt Lake City, United StatesSede
Carregando mapa...
Presença global

Operações

Todos os locais
Salt Lake City, US

Produtos e/ou serviços de USANA Health Sciences

  • CellSentials, comprehensive nutritional supplements including core minerals and vitamins.
  • Procosa, a supplement specifically designed to support joint health.
  • BiOmega, a high-quality fish oil supplement rich in omega-3 fatty acids.
  • HepaPlus, designed to support liver health utilizing innovative nutritional technology.
  • MagneCal D, a balanced formula promoting bone health and mineral supplementation.
  • Rev3 Energy, a cleaner energy drink alternative formulated with natural caffeine and antioxidants.

equipe executiva do USANA Health Sciences

  • Kevin G. GuestCEO & Executive Chairman
  • G. Douglas HekkingChief Financial Officer
  • Walter NootChief Operating Officer
  • P. Joshua FoukasChief Legal Officer, General Counsel & Corporate Secretary
  • Brent L. NeidigChief Commercial Officer
  • Myron W. WentzFounder & Chairman Emeritus
  • John CuomoExecutive Director of Product Development & Technology
  • Peter BenedictChief Information Officer
  • Kathryn ArmstrongChief Scientific Officer
  • Patrique RichardsExecutive Director of Investor Relations & Business Development

Principais indicadores financeiros

Resultados divulgados pela USANA Health Sciences, em USD.

Cap. de mercado
260 mi
Receita (TTM)
913,4 mi
P/L
—
LPA (diluído, TTM)
-1.2
Dividend yield
—
Margem de lucro
-2.4%
Receita e lucro anuais da USANA Health Sciences
Fim do ano fiscalReceitaResultado operacionalLucro líquido
925,3 mi50,9 mi10,8 mi
854,5 mi66,3 mi42 mi
921 mi93,1 mi63,8 mi
998,6 mi107,6 mi69,4 mi